Insights

Expanding Market Access Aeterna Zentaris is actively pursuing commercialization opportunities outside North America, including Europe and the rest of the world, providing potential sales avenues through licensing and direct market entry for Macrilen and other diagnostic products.

Strategic Mergers The recent merger with Ceapro Inc. suggests a strategic move to strengthen the company's product portfolio and market presence, creating opportunities for cross-selling and collaborative sales strategies.

Key Product Adoption Macrilen is currently marketed in the US and Europe, indicating a proven demand for adult growth hormone deficiency diagnostics, which presents ongoing sales opportunities as awareness and reimbursement expand.

Pipeline Development The company is developing new therapies for primary hypoparathyroidism and diagnostic tests for child-onset growth hormone deficiency, offering potential for future sales growth in specialized therapeutic areas.

Growth through Licensing With licensing agreements for the US market and active efforts to license products globally, the company's reliance on strategic partnerships creates opportunities for business development teams to identify new distribution channels and licensing deals.

Cosciens Biopharma Inc. Tech Stack

Cosciens Biopharma Inc. uses 8 technology products and services including Google Cloud CDN, Wix, Module Federation, and more. Explore Cosciens Biopharma Inc.'s tech stack below.

Google Cloud CDN

Content Delivery Network

Wix

Content Management System

Module Federation

Development

Google Cloud

Infrastructure As A Service

Microsoft Word

Office Suites

Priority Hints

Performance

Bootstrap

UI Frameworks

Google Analytics

Web Analytics

Cosciens Biopharma Inc. Email Formats	Example	Percentage
FLast@aezsinc.com	JDoe@aezsinc.com	97%
FMiddleLast@aezsinc.com	JMichaelDoe@aezsinc.com	3%
First.Last@zentaris.com	John.Doe@zentaris.com	100%

Cosciens Biopharma Inc. Email Formats

Example

Percentage

FLast@aezsinc.com

JDoe@aezsinc.com

97%

FMiddleLast@aezsinc.com

JMichaelDoe@aezsinc.com

First.Last@zentaris.com

John.Doe@zentaris.com

100%

Frequently Asked Questions

Where is Cosciens Biopharma Inc.'s headquarters located?

Cosciens Biopharma Inc.'s main headquarters is located at 315 Sigma Drive Summerville, South Carolina 29486 United States. The company has employees across 3 continents, including North AmericaEuropeAsia.

What is Cosciens Biopharma Inc.'s phone number?

You can contact Cosciens Biopharma Inc.'s main corporate office by phone at

+1-847-937-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Cosciens Biopharma Inc.'s official website and social media links?

Cosciens Biopharma Inc.'s official website is zentaris.com and has social profiles on LinkedIn.

What is Cosciens Biopharma Inc.'s NAICS code?

Cosciens Biopharma Inc.'s NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Cosciens Biopharma Inc. have currently?

As of June 2026, Cosciens Biopharma Inc. has approximately 32 employees across 3 continents, including North AmericaEuropeAsia. Key team members include Vice President Business Development: E. G.President And Ceo: D. M.Svp Non-Clinical Development - Chief Scientific Officer (cso): M. T.. Explore Cosciens Biopharma Inc.'s employee directory with LeadIQ.

What industry does Cosciens Biopharma Inc. belong to?

Cosciens Biopharma Inc. operates in the Pharmaceutical Manufacturing industry.

What technology does Cosciens Biopharma Inc. use?

Cosciens Biopharma Inc.'s tech stack includes Google Cloud CDNWixModule FederationGoogle CloudMicrosoft WordPriority HintsBootstrapGoogle Analytics.

What is Cosciens Biopharma Inc.'s email format?

Cosciens Biopharma Inc.'s email format typically follows the pattern of FLast@aezsinc.com. Find more Cosciens Biopharma Inc. email formats with LeadIQ.

When was Cosciens Biopharma Inc. founded?

Cosciens Biopharma Inc. was founded in 1990.

Cosciens Biopharma Inc.

Q: What is Cosciens Biopharma Inc.'s official website and social media links?

Cosciens Biopharma Inc.'s official website is zentaris.com. Cosciens Biopharma Inc. has social profiles on LinkedIn.

Q: How many employees does Cosciens Biopharma Inc. have currently?

Cosciens Biopharma Inc. has approximately 32 employees.

Q: What technology does Cosciens Biopharma Inc. use?

Cosciens Biopharma Inc.'s tech stack includes HTTP/3, Google Cloud, Wix, Priority Hints, HSTS.

Q: What is Cosciens Biopharma Inc.'s NAICS code?

Cosciens Biopharma Inc.'s NAICS code is 3254 (Pharmaceutical and Medicine Manufacturing).

Pharmaceutical ManufacturingSouth Carolina, United States11-50 Employees

Aeterna Zentaris Inc. is a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests. The Company’s lead product, Macrilen™ (macimorelin), is the first and only U.S. FDA and European Commission approved oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). Macrilen™ is currently marketed in the United States through a license agreement with Novo Nordisk and Aeterna Zentaris receives double-digit royalties on sales. Aeterna Zentaris owns all rights to macimorelin outside of the U.S. and Canada.

Aeterna Zentaris is also leveraging the clinical success and compelling safety profile of macimorelin to develop it for the diagnosis of child-onset growth hormone deficiency (CGHD), an area of significant unmet need. 

The Company is actively pursuing business development opportunities for the commercialization of macimorelin in Europe and the rest of the world, in addition to other non-strategic assets to monetize their value.

Insights

Similar companies to Cosciens Biopharma Inc.

Roche

Sanofi

Astellas Pharma

Ferring Pharmaceuticals

Ipsen

Pfizer

Crinetics Pharmaceuticals

Novartis